Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-022143

Director acquired 7,605 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Molineaux Christopher P. Director 2017-03-17 Option exercise +6,702 $0.41 $2,748 6,702 D: show line 1 in the form
Molineaux Christopher P. Director 2017-03-17 Option exercise +592 $1.52 $900 7,294 D: show line 2 in the form
Molineaux Christopher P. Director 2017-03-17 Option exercise +311 $0.72 $224 7,605 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Molineaux Christopher P. Director 2017-03-17 Option exercise · Stock option (right to buy) −6,702 1,993 D: show line 4 in the form
Molineaux Christopher P. Director 2017-03-17 Option exercise · Stock option (right to buy) −592 462 D: show line 5 in the form
Molineaux Christopher P. Director 2017-03-17 Option exercise · Stock option (right to buy) −311 171 D: show line 6 in the form
Loading xslF345X03/doc4.xml…